Showing 1 – 5 of 5
Relevance | Newest | Oldest |
  • JAMA Cardiology Original Investigation
    April 17, 2024

    Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial

    Yi听Li,听MD; Jing听Li,听MD; Bin听Wang,听MD; Quanmin听Jing,听MD; Yujie听Zeng,听MD; Aijie听Hou,听MD; Zhifang听Wang,听MD; Aijun听Liu,听MD; Jinliang听Zhang,听MD; Yaojun听Zhang,听MD; Ping听Zhang,听MD; Daming听Jiang,听MD; Bin听Liu,听MD; Jiamao听Fan,听MD; Jun听Zhang,听MD; Li听Li,听MD; Guohai听Su,听MD; Ming听Yang,听MD; Weihong听Jiang,听MD; Peng听Qu,听MD; Hesong听Zeng,听MD, PhD; Lu听Li,听MD; Miaohan听Qiu,听MD; Leisheng听Ru,听MD; Shaoliang听Chen,听MD; Yujie听Zhou,听MD; Shubin听Qiao,听MD; Gregg W.听Stone,听MD; Dominick J.听Angiolillo,听MD, PhD; Yaling听Han,听MD; OPT-BIRISK Investigators
    Abstract Full Text
    online first
    JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0534

    This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.

  • JAMA Original Investigation
    October 24, 2023

    Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial

    Yuejin听Yang,听MD, PhD; Xiangdong听Li,听MD, PhD; Guihao听Chen,听MD, PhD; Ying听Xian,听MD, PhD; Haitao听Zhang,听MD, PhD; Yuan听Wu,听MD; Yanmin听Yang,听MD; Jianhua听Wu,听MD; Chuntong听Wang,听MD; Shenghu听He,听MD; Zhong听Wang,听MD; Yixin听Wang,听MD; Zhifang听Wang,听MD; Hui听Liu,听MD; Xiping听Wang,听MD; Minzhou听Zhang,听MD; Jun听Zhang,听MD, PhD; Jia听Li,听MD; Tao听An,听MD; Hao听Guan,听MD; Lin听Li,听MD; Meixia听Shang,听MD; Chen听Yao,听MD; Yaling听Han,听MD, PhD; Boli听Zhang,听MD; Runlin听Gao,听MD; Eric D.听Peterson,听MD, MPH; CTS-AMI Investigators
    Abstract Full Text
    free access
    JAMA. 2023; 330(16):1534-1545. 10.1001/jama.2023.19524

    This randomized clinical trial assesses the efficacy of Tongxinluo, a traditional Chinese medicine compound, vs placebo in improving clinical outcomes in patients with ST-segment elevation myocardial infarction.

  • JAMA Cardiology Original Investigation
    March 16, 2022

    Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China

    Yongchen听Hao,听PhD; Dong听Zhao,听MD, PhD; Jing听Liu,听MD, PhD; Jun听Liu,听MD; Na听Yang,听PhD; Yong听Huo,听MD; Gregg C.听Fonarow,听MD; Junbo听Ge,听MD, PhD; Louise听Morgan,听MSN; Changsheng听Ma,听MD; Yaling听Han,听MD; Sidney C.听Smith听Jr,听MD; CCC-ACS Investigators
    Abstract Full Text
    free access has multimedia
    JAMA Cardiol. 2022; 7(5):484-491. 10.1001/jamacardio.2022.0117

    This quality improvement study analyzes data from a nationwide registry in China to investigate how care is provided in relation to guideline recommendations for patients hospitalized with ST-segment elevation myocardial infarction.

  • JAMA Comment & Response
    August 11, 2015

    Varying Responses to Antithrombotic Treatment by Race/Ethnicity鈥擱eply

    Yaling听Han,听MD, PhD; Yi听Li,听MD; Gregg W.听Stone,听MD
    Abstract Full Text
    JAMA. 2015; 314(6):625-625. 10.1001/jama.2015.7384
  • JAMA Original Investigation
    April 7, 2015

    Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The BRIGHT Randomized Clinical Trial

    Yaling听Han,听MD, PhD; Jincheng听Guo,听MD; Yang听Zheng,听MD; Hongyun听Zang,听MD; Xi听Su,听MD; Yu听Wang,听MD; Shaoliang听Chen,听MD; Tiemin听Jiang,听MD; Ping听Yang,听MD; Jiyan听Chen,听MD; Dongju听Jiang,听MD; Quanmin听Jing,听MD; Zhenyang听Liang,听MBBS; Haiwei听Liu,听MD; Xin听Zhao,听MD; Jing听Li,听MBBS; Yi听Li,听MD; Bo听Xu,听MBBS; Gregg W.听Stone,听MD; for the BRIGHT Investigators
    Abstract Full Text
    free access
    JAMA. 2015; 313(13):1336-1346. 10.1001/jama.2015.2323

    This randomized superiority trial in China found that among patients undergoing PCI, bivalirudin was associated with reduced adverse effects compared with heparin alone and heparin plus tirofiban.